The global health community is on alert following the declaration of a Public Health Emergency of International Concern (PHEIC) concerning an outbreak of Ebola disease caused by the Bundibugyo virus (BVD) in the Democratic Republic of Congo (DRC) and Uganda. This critical development, announced by the World Health Organization (WHO) Director-General on May 16, 2026, underscores the severity and potential for international spread of this particular strain of Ebola. The alarm was first raised on May 5, 2026, when WHO received reports of an unknown illness with a high death toll in the Mongbwalu Health Zone of Ituri Province, DRC, notably affecting several healthcare workers. After rapid investigations and laboratory analysis, the Institut national de recherche biomédicale (INRB) in Kinshasa confirmed the presence of Bundibugyo virus on May 15, 2026. This confirmation led the DRC's Ministry of Public Health to officially declare its 17th Ebola disease outbreak. ## Understanding the Bundibugyo Virus Disease (BVD) Bundibugyo virus is one of several species within the *Ebolavirus* genus, known for causing severe, often fatal, hemorrhagic fever in humans. Like other forms of Ebola, BVD is characterized by symptoms such as sudden onset of fever, intense weakness, muscle pain, headache, and sore throat, followed by vomiting, diarrhea, rash, impaired kidney and liver function, and in some cases, internal and external bleeding. The incubation period, from infection to the onset of symptoms, typically ranges from 2 to 21 days. Transmission occurs through direct contact with the blood, secretions, organs, or other bodily fluids of infected people, and from surfaces and materials (e.g., bedding, clothing) contaminated with these fluids. Healthcare workers caring for infected patients without proper infection control measures are at high risk, as are family members providing care. One crucial distinction for Bundibugyo virus, compared to the more commonly known Zaire Ebola virus, is the lack of a licensed vaccine or specific antiviral treatment currently available. This makes early supportive care—such as fluid management, maintaining oxygen status, and treating complicating infections—even more vital for survival, with past outbreaks showing case fatality rates between 30% and 50%. ## The Outbreak's Origins and Spread in DRC The initial cluster of cases was identified in Mongbwalu Health Zone, a significant mining area known for high population movement, which poses a substantial risk for disease dissemination. Cases subsequently migrated to other health zones, including Rwampara and Bunia, as individuals sought medical care. The first confirmed suspected case, a healthcare worker, developed symptoms on April 24, 2026, and sadly succumbed to the illness in Bunia. As of May 15, 2026, the DRC reported 246 suspected cases and 80 deaths across three health zones: Rwampara, Mongbwalu, and Bunia. A concerning trend shows that most suspected cases are among individuals aged 20 to 39, with over 60% being female, suggesting a significant risk of transmission within households and among caregivers. Efforts to identify and monitor contacts have been challenging due to insecurity and movement restrictions in affected regions, leading to some listed contacts developing symptoms and dying before isolation could be effectively implemented. ## Uganda's Proactive Response to Imported Cases Cross-border transmission is a significant concern, given Ituri province's proximity to Uganda and South Sudan and its role as a commercial hub. This concern materialized when Uganda's Ministry of Health confirmed an imported case of BVD on May 15, 2026. An elderly Congolese man, who had traveled from the DRC, was admitted to a private hospital in Kampala with severe symptoms and died shortly thereafter. Laboratory testing confirmed Bundibugyo virus. A second imported case, unrelated to the first and also returning from DRC, was confirmed in Kampala the following day. Uganda has swiftly initiated response measures, and crucially, no local transmission has been identified within Uganda's borders as of the latest reports, indicating effective initial containment efforts. ## What a Public Health Emergency of International Concern (PHEIC) Means The declaration of a PHEIC by the WHO Director-General is a formal recognition under the International Health Regulations (IHR 2005) that an event poses a significant risk to the health of people across more than one country and requires a coordinated international response. This declaration is made after careful consultation with the affected countries and signifies that the outbreak is serious, unusual, or unexpected, and may carry implications for public health beyond the affected state's national border. For this BVD outbreak, the PHEIC declaration mobilizes global resources, enhances surveillance, facilitates information sharing, and prompts international cooperation to contain the virus and prevent further spread. ## The Comprehensive Response Effort The response to the Bundibugyo virus outbreak is multi-faceted and heavily supported by the WHO. Key measures include deploying rapid response teams to affected areas for swift investigation and intervention, delivering essential medical supplies, and strengthening surveillance systems to identify and track new cases and contacts. Laboratory capabilities are being bolstered for rapid confirmation of diagnoses, and infection prevention and control (IPC) assessments are underway to safeguard healthcare facilities and staff, a particularly vulnerable group. Establishing safe treatment centers is paramount to provide isolation and critical supportive care for patients while minimizing further transmission. Community engagement is also a cornerstone of the response, educating the public on the virus, its transmission, and preventive measures, as well as fostering trust and cooperation for safe burial practices and contact tracing. WHO is actively coordinating these efforts, supporting case management protocols, and aiding in cross-border preparedness to prevent regional exportation and bolster vigilance in neighboring countries. ## Staying Safe: Prevention and Public Awareness Given the absence of a vaccine or specific treatment for Bundibugyo virus, prevention and public awareness are critical. Communities in affected and at-risk areas are advised to: * **Practice rigorous hand hygiene:** Regularly wash hands with soap and water or use alcohol-based hand sanitizer. * **Avoid contact with bodily fluids:** Do not touch the blood, secretions, organs, or other bodily fluids of sick or deceased individuals suspected of having BVD. * **Safe burial practices:** Adhere to safe burial practices as advised by health authorities, which minimize direct contact with the deceased. * **Seek early medical care:** If you develop symptoms consistent with BVD, isolate yourself immediately and seek medical attention at a designated facility. * **Report suspected cases:** Alert health authorities to any suspected cases or unusual deaths in your community. * **Avoid contact with wild animals:** Limit contact with wild animals, especially bats, monkeys, and apes, and avoid consuming bushmeat, as these can be reservoirs for the virus. ## Broader Implications and Global Vigilance The declaration of this BVD outbreak as a PHEIC highlights the constant threat posed by emerging and re-emerging infectious diseases. The geographical location of the outbreak, in a high-traffic mining area bordering multiple countries, amplifies the risk of regional and even global spread. This event underscores the vital importance of robust national health surveillance systems, rapid diagnostic capabilities, and efficient, coordinated international responses. Global vigilance remains essential to contain this outbreak and protect public health worldwide.